AFP
TMO icon

Ausdal Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History

Ausdal Financial Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$456K Sell
910
-54
-6% -$25.9K 0.02% 670
2026
Q1 		$474K Sell
964
-1,077
-53% -$584K 0.02% 603
2025
Q4 		$1.18M Buy
2,041
+1,091
+115% +$617K 0.05% 318
2025
Q3 		$461K Buy
+950
New +$442K 0.02% 583
2023
Q3 		– Sell
-485
Closed -$253K – 464
2023
Q2 		$253K Sell
485
-24
-5% -$13K 0.03% 357
2023
Q1 		$293K Buy
509
+32
+7% +$18K 0.04% 355
2022
Q4 		$262K Sell
477
-64
-12% -$33.9K 0.04% 370
2022
Q3 		$275K Buy
541
+10
+2% +$5.6K 0.04% 349
2022
Q2 		$289K Sell
531
-5
-0.9% -$2.75K 0.04% 347
2022
Q1 		$317K Buy
536
+24
+5% +$13.8K 0.04% 363
2021
Q4 		$342K Sell
512
-21
-4% -$13.1K 0.05% 353
2021
Q3 		$305K Buy
533
+47
+10% +$25.8K 0.05% 358
2021
Q2 		$245K Sell
486
-10
-2% -$4.72K 0.04% 386
2021
Q1 		$226K Buy
496
+4
+0.8% +$1.91K 0.04% 394
2020
Q4 		$229K Buy
492
+4
+0.8% +$1.88K 0.04% 369
2020
Q3 		$216K Buy
+488
New +$202K 0.05% 320
2020
Q2 		– Sell
-626
Closed -$205K – 310
2020
Q1 		$205K Buy
+626
New +$197K 0.07% 251
2016
Q1 		– Sell
-60
Closed -$9K – 947
2015
Q4 		$9K Buy
+60
New +$8K ﹤0.01% 945

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ausdal Financial Partners's TMO Position: Q2 2026 in Review

Ausdal Financial Partners reduced its Thermo Fisher Scientific (TMO) stake by 5.6% in Q2 2026, selling an estimated $25.9K and leaving 910 shares worth $456K. The position accounts for 0.02% of the portfolio, ranked #670.

Ausdal Financial Partners first reported a position in TMO in Q4 2015 and has held it in 18 quarters since. The position peaked at $1.18M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ausdal Financial Partners held 910 shares of Thermo Fisher Scientific worth $456K as of Q2 2026.
  • Ausdal Financial Partners sold 54 Thermo Fisher Scientific shares in Q2 2026, an estimated $25.9K.
  • Thermo Fisher Scientific made up 0.02% of Ausdal Financial Partners's portfolio in Q2 2026, its #670 holding.
  • Ausdal Financial Partners first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 18 quarters since.
  • Ausdal Financial Partners's Thermo Fisher Scientific position peaked at $1.18M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.